Reelin Deficiency Delays Mammary Tumor Growth and Metastatic Progression

Area of Science:

• Oncology
• Developmental Biology
• Immunology

Background:

• Reelin is a secreted glycoprotein crucial for nervous system development.
• Altered reelin expression is linked to various cancers, including breast cancer.
• Reelin's role in mammary gland stromal cells and breast cancer progression is unclear.

Purpose of the Study:

• To investigate the impact of host-derived reelin on breast cancer progression using a syngeneic mouse model.
• To determine if stromal reelin influences tumor growth, metastasis, and the tumor microenvironment.

Main Methods:

• Syngeneic mouse mammary tumor transplantation model.
• Comparison of tumor growth and lung metastasis in reelin-deficient (rl Orl-/-) and wild-type mice.
• Immunohistochemistry and gene expression analysis of primary tumors and macrophages.

Main Results:

• Tumors grew slower and lung metastasis was delayed in reelin-deficient mice.
• Tumors in deficient mice showed reduced vascularization and increased macrophage infiltration.
• Loss of host reelin altered M1/M2 macrophage markers and enhanced M1-associated cytokine production (iNOS, IL-6).

Conclusions:

• Host-derived reelin promotes breast cancer progression and metastasis.
• Reelin influences the tumor microenvironment, including angiogenesis and macrophage polarization.
• Reelin may represent a novel therapeutic target in breast cancer treatment.